These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 3232180)
1. Suramin and metronidazole in the treatment of Trypanosoma brucei rhodesiense. Arroz J; Djedje M Trans R Soc Trop Med Hyg; 1988; 82(3):421. PubMed ID: 3232180 [No Abstract] [Full Text] [Related]
2. Metronidazole and suramin combination in the treatment of arsenical refractory Rhodesian sleeping sickness--a case study. Foulkes JR Trans R Soc Trop Med Hyg; 1996; 90(4):422. PubMed ID: 8882195 [No Abstract] [Full Text] [Related]
3. [In vivo resistance to strains of Trypanosoma rhodesiense, Mozambique, 1985]. Pérez Martín O; Lastre González M; Urban M; Shwalbach J Rev Cubana Med Trop; 1991; 43(3):189-93. PubMed ID: 9768188 [TBL] [Abstract][Full Text] [Related]
5. 100 years since the publication of the suramin formula. Steverding D; Troeberg L Parasitol Res; 2023 Dec; 123(1):11. PubMed ID: 38057659 [TBL] [Abstract][Full Text] [Related]
6. Suramin treatment of experimental Trypanosoma brucei infection of the central nervous system. Jennings FW Trans R Soc Trop Med Hyg; 1995; 89(6):677. PubMed ID: 8594694 [No Abstract] [Full Text] [Related]
7. Studies on the efficacy of DL-alpha-difluoromethylornithine (DFMO) associated with bleomycin and suramin for treatment of mice infected with metacyclic forms of Trypanosoma brucei brucei. Demey F Vet Res Commun; 1987; 11(3):271-4. PubMed ID: 2442883 [TBL] [Abstract][Full Text] [Related]
8. New drug combination for experimental late-stage African trypanosomiasis: DL-alpha-difluoromethylornithine (DFMO) with suramin. Clarkson AB; Bienen EJ; Bacchi CJ; McCann PP; Nathan HC; Hutner SH; Sjoerdsma A Am J Trop Med Hyg; 1984 Nov; 33(6):1073-7. PubMed ID: 6439061 [TBL] [Abstract][Full Text] [Related]
9. Treatment of late stage rhodesiense trypanosomiasis using suramin and eflornithine: report of six cases. Clerinx J; Taelman H; Bogaerts J; Vervoort T Trans R Soc Trop Med Hyg; 1998; 92(4):449-50. PubMed ID: 9850406 [No Abstract] [Full Text] [Related]
10. Induction of human serum-sensitive Trypanosoma brucei stabilates into human serum-resistant "T. rhodesiense". Jennings FW; Urquhart GM Trans R Soc Trop Med Hyg; 1985; 79(1):80-5. PubMed ID: 3992646 [TBL] [Abstract][Full Text] [Related]
11. Suramin action in African trypanosomes involves a RuvB-like DNA helicase. Albisetti A; Hälg S; Zoltner M; Mäser P; Wiedemar N Int J Parasitol Drugs Drug Resist; 2023 Dec; 23():44-53. PubMed ID: 37757728 [TBL] [Abstract][Full Text] [Related]
12. 100 Years of Suramin. Wiedemar N; Hauser DA; Mäser P Antimicrob Agents Chemother; 2020 Feb; 64(3):. PubMed ID: 31844000 [TBL] [Abstract][Full Text] [Related]
13. Establishment of a partly DFMO-sensitive primate model of Trypanosoma rhodesiense sleeping sickness. Burudi EM; Karanja SM; Njue AI; Githiori JB; Ndung'u JM Acta Trop; 1995 Mar; 59(1):71-3. PubMed ID: 7785528 [No Abstract] [Full Text] [Related]
14. Chemotherapy of late-stage trypanosomiasis: the effect of the nitrothiazole compounds. Jennings FW Trans R Soc Trop Med Hyg; 1987; 81(4):616. PubMed ID: 3445346 [No Abstract] [Full Text] [Related]
15. Suramin and minocycline treatment of experimental African trypanososmiasis at an early stage of parasite brain invasion. Amin DN; Masocha W; Ngan'dwe K; Rottenberg M; Kristensson K Acta Trop; 2008 Apr; 106(1):72-4. PubMed ID: 18329619 [TBL] [Abstract][Full Text] [Related]
16. Treatment with suramin and 2-substituted 5-nitroimidazoles of chronic murine Trypanosoma brucei infections with central nervous system involvement. Jennings FW; Urquhart GM; Murray PK; Miller BM Trans R Soc Trop Med Hyg; 1983; 77(5):693-8. PubMed ID: 6659049 [TBL] [Abstract][Full Text] [Related]
17. The in vitro and in vivo effects of metronidazole and chloroquine on Trypanosoma brucei brucei. Otigbuo IN; Woo PT J Parasitol; 1988 Apr; 74(2):201-6. PubMed ID: 3357110 [TBL] [Abstract][Full Text] [Related]
18. Chemotherapy of CNS-trypanosomiasis: the combined use of the arsenicals and nitro-compounds. Jennings FW Trop Med Parasitol; 1991 Jun; 42(2):139-42. PubMed ID: 1896771 [TBL] [Abstract][Full Text] [Related]
19. Effects of the ornithine decarboxylase inhibitors DL-alpha-difluoromethylornithine and alpha-monofluoromethyldehydroornithine methyl ester alone and in combination with suramin against Trypanosoma brucei brucei central nervous system models. Bacchi CJ; Nathan HC; Clarkson AB; Bienen EJ; Bitonti AJ; McCann PP; Sjoerdsma A Am J Trop Med Hyg; 1987 Jan; 36(1):46-52. PubMed ID: 3101528 [TBL] [Abstract][Full Text] [Related]
20. Physiological and proteomic profiles of Trypanosoma brucei rhodesiense parasite isolated from suramin responsive and non-responsive HAT patients in Busoga, Uganda. Mutuku CN; Bateta R; Rono MK; Njunge JM; Awuoche EO; Ndung'u K; Mang'era CM; Akoth MO; Adung'a VO; Ondigo BN; Mireji PO Int J Parasitol Drugs Drug Resist; 2021 Apr; 15():57-67. PubMed ID: 33588295 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]